Fig. 2: Associations between baseline blood-based BD-tau, t-tau and NfL with baseline and longitudinal MRI-derived Alzheimer’s disease meta region of interest (AD meta ROI).
From: Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
A–C show associations of blood-based neurodegeneration markers with baseline and longitudinal AD meta ROI. All statistical tests were two-sided, and unadjusted for multiple comparisons. All plots display model predictions generated with the “ggeffects” R package. The lines display associations between the biomarker at −1SD, Mean and +1SD and the dependent variable at baseline and over time.
